Decoding Biomarkers and Checkpoint Inhibitor Mechanisms in Non-Small Cell Lung Cancer

Decoding Biomarkers and Checkpoint Inhibitor Mechanisms in Non-Small Cell Lung Cancer is organized by Med Learning Group.,Release Date: May 24, 2022,Expiration Date: May 24, 2023,Program Overview:,This activity invites learners to experience a virtual world illustrating personalized therapy for advanced non-small cell lung cancer (NSCLC). It provides a unique opportunity for learning about checkpoint inhibitor mechanisms in NSCLC, important biomarkers used to guide clinical decisions, and immune-related adverse events.,Learning Objectives:,Upon the completion of this program, attendees should be able to:,• Evaluate the mechanisms involved in NSCLC immune escape that contribute to lung cancer pathogenesis and strategies to mitigate these pathways,• Analyze key clinical trial data regarding immune checkpoint inhibitors in the front-line management of NSCLC,• Summarize findings related to biomarker expression and translate findings into appropriate clinical action in the first-line management of NSCLC